 Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores
Tatva Chintan Pharma Chem Ltd consolidated Q2FY26 PAT climbs to Rs. 9.91 crores GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore
GPT Infraprojects Ltd receives contract worth Rs. 37.8 crore Dr Lal PathLabs Limited recommends 1:1 bonus issue
Dr Lal PathLabs Limited recommends 1:1 bonus issue RITES signs MoU with Shipping Corporation of India
RITES signs MoU with Shipping Corporation of India XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector
XTGlobal announces new client win for Circulus AP Automation Solution in the U.S. Construction Sector 
              The Compensation Committee of Directors of Ajanta Pharma Ltd at its meeting held on May 06, 2016, has allotted 3,750 fully paid up equity shares of Rs. 2/- each. These shares have been allotted upon exercise of options granted to an employee under Employees Stock Option Scheme - 2011 of the Company.
In view of the above, the paid up capital of the Company stand increased to Rs. 17,60,10,000 consisting 8,80,05,000 equity shares of Rs. 2/- each.
Shares of AJANTA PHARMA LTD. was last trading in BSE at Rs.1542.15 as compared to the previous close of Rs. 1517.55. The total number of shares traded during the day was 13637 in over 1229 trades.
The stock hit an intraday high of Rs. 1548 and intraday low of 1515.85. The net turnover during the day was Rs. 20934174.